MELA Sciences, Inc. to Participate in the Fall Clinical Dermatology Conference (MELA Sciences Inc)

(Source: MELA Sciences Inc) Leading Dermatologists to Present Clinical Findings in Four Poster Presentations at the 32nd Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada IRVINGTON, N.Y., Oct. 16, 2013 (GLOBE NEWSWIRE) - MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced that the company will be participating in the 32nd Annual Fall Clinical Dermatology Conference taking place October 17 - 20, 2013 in Las Vegas, Nevada. The Fall Clinical Dermatology Conference is...